Am. J. Respir. Cell Mol. Biol., Volume 25, Number 1, July, 2001 21-25

Salt-Independent Abnormality of Antimicrobial Activity in Cystic Fibrosis Airway Surface Fluid

Robert Bals, Daniel J. Weiner, Rupalie L. Meegalla, Frank Accurso, and James M. Wilson

Institute for Human Gene Therapy, Departments of Medicine and Molecular and Cellular Engineering, University of Pennsylvania; The Wistar Institute; Division of Pulmonary Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and The Children's Hospital and the University of Colorado School of Medicine, Denver, Colorado

The link between the genetic defect in cystic fibrosis (CF) and the recently described breach in pulmonary host defense has focused on the role of salt and water metabolism in the airways. Using a human bronchial xenograft model we demonstrate a salt-independent abnormality in bacterial killing in CF airway surface fluid (ASF). Biochemical characterization implicates the absence or dysfunction of a molecule critical to the constitution of normal bacterial killing. Our study suggests that CF transmembrane conductance regulator (CFTR) deficiency causes a primary abnormality in the composition of ASF that leads to a salt-independent defect in host defense. Importantly, this defect is corrected by adenovirus-mediated gene transfer of CFTR.

This article has been cited by other articles:

				R. Bucki, A. G. Sostarecz, F. J. Byfield, P. B. Savage, and P. A. Janmey Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum J. Antimicrob. Chemother., September 1, 2007; 60(3): 535 - 545. [Abstract] [Full Text] [PDF]

				P. S. Hiemstra Antimicrobial peptides in the real world: implications for cystic fibrosis Eur. Respir. J., April 1, 2007; 29(4): 617 - 618. [Full Text] [PDF]

				R. Bucki, F. J. Byfield, and P. A. Janmey Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum Eur. Respir. J., April 1, 2007; 29(4): 624 - 632. [Abstract] [Full Text] [PDF]

				T. J. Moraes, J. Plumb, R. Martin, E. Vachon, V. Cherepanov, A. Koh, C. Loeve, J. Jongstra-Bilen, J. H. Zurawska, J. V. Kus, et al. Abnormalities in the Pulmonary Innate Immune System in Cystic Fibrosis Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 364 - 374. [Abstract] [Full Text] [PDF]

				P. B. Davis Cystic Fibrosis Since 1938 Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 475 - 482. [Abstract] [Full Text] [PDF]

				H. Ishimoto, H. Mukae, Y. Date, T. Shimbara, M. S. Mondal, J. Ashitani, T. Hiratsuka, S. Kubo, S. Kohno, and M. Nakazato Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia Eur. Respir. J., February 1, 2006; 27(2): 253 - 260. [Abstract] [Full Text] [PDF]

				W. Xiao, Y.-P. Hsu, A. Ishizaka, T. Kirikae, and R. B. Moss Sputum Cathelicidin, Urokinase Plasminogen Activation System Components, and Cytokines Discriminate Cystic Fibrosis, COPD, and Asthma Inflammation Chest, October 1, 2005; 128(4): 2316 - 2326. [Abstract] [Full Text] [PDF]

				D. K. Meyerholz, B. Grubor, J. M. Gallup, H. D. Lehmkuhl, R. D. Anderson, T. Lazic, and M. R. Ackermann Adenovirus-Mediated Gene Therapy Enhances Parainfluenza Virus 3 Infection in Neonatal Lambs J. Clin. Microbiol., October 1, 2004; 42(10): 4780 - 4787. [Abstract] [Full Text] [PDF]

				U. Sajjan, S. Keshavjee, and J. Forstner Responses of Well-Differentiated Airway Epithelial Cell Cultures from Healthy Donors and Patients with Cystic Fibrosis to Burkholderia cenocepacia Infection Infect. Immun., July 1, 2004; 72(7): 4188 - 4199. [Abstract] [Full Text] [PDF]

				R. Bals and P.S. Hiemstra Innate immunity in the lung: how epithelial cells fight against respiratory pathogens Eur. Respir. J., February 1, 2004; 23(2): 327 - 333. [Abstract] [Full Text] [PDF]

				J J Oppenheim, A Biragyn, L W Kwak, and D Yang Roles of antimicrobial peptides such as defensins in innate and adaptive immunity Ann Rheum Dis, November 1, 2003; 62(90002): ii17 - 21. [Abstract] [Full Text] [PDF]

				D. J. Weiner, R. Bucki, and P. A. Janmey The Antimicrobial Activity of the Cathelicidin LL37 Is Inhibited by F-actin Bundles and Restored by Gelsolin Am. J. Respir. Cell Mol. Biol., June 1, 2003; 28(6): 738 - 745. [Abstract] [Full Text] [PDF]

				S. Huang, T. Dudez, I. Scerri, M. A. Thomas, B. N. G. Giepmans, S. Suter, and M. Chanson Defective Activation of c-Src in Cystic Fibrosis Airway Epithelial Cells Results in Loss of Tumor Necrosis Factor-alpha -induced Gap Junction Regulation J. Biol. Chem., February 28, 2003; 278(10): 8326 - 8332. [Abstract] [Full Text] [PDF]

				S. SCHALLER-BALS, A. SCHULZE, and R. BALS Increased Levels of Antimicrobial Peptides in Tracheal Aspirates of Newborn Infants during Infection Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 992 - 995. [Abstract] [Full Text] [PDF]

				T. W. Ferkol and D. C. Look Chinks in the Armor of the Airway . Pseudomonas Infection in the Cystic Fibrosis Lung Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 11 - 13. [Full Text] [PDF]